Search research articles
Contact Us
Filters
Showing results (41-50 of 50) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 50 results.
BJU International
|
February 27, 2003
Time after surgery, symptoms and well-being in survivors of urinary bladder cancer
L Henningsohn, H Wijkström, J Pedersen, et al.
BJU International
|
September 17, 2002
Three-month neoadjuvant hormonal therapy before radical prostatectomy: a 7-year follow-up of a randomized controlled trial
G Aus, P-A Abrahamsson, G Ahlgren, et al.
European Urology
|
January 1, 1996
The risk of malignancy in the surgical margin at radical prostatectomy reduced almost three-fold in patients given neo-adjuvant hormone treatment
J Hugosson, P A Abrahamsson, G Ahlgren, et al.
BJU International
|
February 27, 2004
Population-based screening for prostate cancer by measuring free and total serum prostate-specific antigen in Sweden
J Hugosson, G Aus, S Bergdahl, et al.
The Journal of Urology
|
May 23, 1998
Hormonal treatment before radical prostatectomy: a 3-year followup
G Aus, P A Abrahamsson, G Ahlgren, et al.
European Urology
|
August 31, 2001
EAU guidelines on prostate cancer
G Aus, C C Abbou, D Pacik, et al.
Acta Physiologica Scandinavica
|
March 1, 1983
Cardiovascular effects of antihypertensive renomedullary lipids (APRL and ANRL)
E E Muirhead, B Folkow, L W Byers, et al.
European Urology
|
July 28, 2005
EAU guidelines on prostate cancer
G Aus, C C Abbou, M Bolla, et al.
European Urology
|
February 15, 2000
Current status of minimally invasive treatment options for localized prostate carcinoma
H P Beerlage, S Thüroff, S Madersbacher, et al.
European Urology
|
January 1, 1993
Neoadjuvant GnRH-agonist treatment (triptorelin and cyproterone acetate for flare protection) and total prostatectomy
M Häggman, M Hellström, G Aus, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 50) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 50 results.
BJU International
|
February 27, 2003
Time after surgery, symptoms and well-being in survivors of urinary bladder cancer
L Henningsohn, H Wijkström, J Pedersen, et al.
BJU International
|
September 17, 2002
Three-month neoadjuvant hormonal therapy before radical prostatectomy: a 7-year follow-up of a randomized controlled trial
G Aus, P-A Abrahamsson, G Ahlgren, et al.
European Urology
|
January 1, 1996
The risk of malignancy in the surgical margin at radical prostatectomy reduced almost three-fold in patients given neo-adjuvant hormone treatment
J Hugosson, P A Abrahamsson, G Ahlgren, et al.
BJU International
|
February 27, 2004
Population-based screening for prostate cancer by measuring free and total serum prostate-specific antigen in Sweden
J Hugosson, G Aus, S Bergdahl, et al.
The Journal of Urology
|
May 23, 1998
Hormonal treatment before radical prostatectomy: a 3-year followup
G Aus, P A Abrahamsson, G Ahlgren, et al.
European Urology
|
August 31, 2001
EAU guidelines on prostate cancer
G Aus, C C Abbou, D Pacik, et al.
Acta Physiologica Scandinavica
|
March 1, 1983
Cardiovascular effects of antihypertensive renomedullary lipids (APRL and ANRL)
E E Muirhead, B Folkow, L W Byers, et al.
European Urology
|
July 28, 2005
EAU guidelines on prostate cancer
G Aus, C C Abbou, M Bolla, et al.
European Urology
|
February 15, 2000
Current status of minimally invasive treatment options for localized prostate carcinoma
H P Beerlage, S Thüroff, S Madersbacher, et al.
European Urology
|
January 1, 1993
Neoadjuvant GnRH-agonist treatment (triptorelin and cyproterone acetate for flare protection) and total prostatectomy
M Häggman, M Hellström, G Aus, et al.
Page
of 5